{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:14:17Z","timestamp":1792545257213,"version":"4.5.0"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100010733","name":"B\u00f8rnecancerfonden","doi-asserted-by":"publisher","award":["2023\u2010001124"],"award-info":[{"award-number":["2023\u2010001124"]}],"id":[{"id":"10.13039\/100010733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R279\u2010A16411"],"award-info":[{"award-number":["R279\u2010A16411"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      Vincristine\u2010induced peripheral neuropathy (VIPN) is a common side effect in children and adolescents treated with vincristine. Assessing VIPN, especially in young children, is challenging due to a lack of sensitive tools. This limits our understanding of the nature and risk factors of VIPN. This study aimed to investigate neurofilament light chain (NfL) as a biomarker of nerve damage\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Induced pluripotent stem cells (iPSC) were differentiated into sensory neurons (SN) and exposed to incremental concentrations of vincristine. Cells were fixed and immunolabelled to showcase structural damage and media were collected for assessment of NfL. Furthermore, we performed a prospective, self\u2010controlled clinical trial in 21 children with acute lymphoblastic leukaemia (ALL) during their 36\u2010day weekly vincristine induction and assessed VIPN symptoms using Common Terminology Criteria for Adverse Events (CTCAE). Blood was drawn before or shortly after initiating treatment and every week following initiation of treatment to assess NfL in serum (sNfL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      studies using iPSC\u2010SN showed that vincristine exposure caused substantial structural damage and a dose\u2010dependent increase in NfL release to cell medium. In this pilot study, median sNfL increased from 8.9\u00a0pg\/mL pre\u2010treatment to 158.5\u00a0pg\/mL by day 36, coinciding with worsening sensory and motor symptoms. However, in this pilot study, no statistically significant correlation between sNfL levels and CTCAE was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Vincristine causes concentration\u2010dependent NfL release\n                      <jats:italic>in vitro<\/jats:italic>\n                      , and sNfL levels increase during vincristine treatment. Further studies are needed to investigate sNfL's potential as a biomarker of VIPN in children with ALL.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70599","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:31:32Z","timestamp":1779334292000},"page":"3180-3190","source":"Crossref","is-referenced-by-count":2,"title":["Neurofilament light chain as\n                    <i>in vitro<\/i>\n                    and clinical biomarker of vincristine\u2010induced peripheral neuropathy"],"prefix":"10.1002","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6193-5201","authenticated-orcid":false,"given":"Peter Erik Lotko","family":"Pontoppidan","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Clinic of Pediatric Oncology and Hematology Rigshospitalet University of Copenhagen  Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bach","family":"Vase","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Research Laboratory, Department of Pediatrics and Adolescent Medicine, Rigshospitalet University of Copenhagen  Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mortensen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health University of Southern Denmark University of Southern Denmark  Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Andres\u2010Jensen","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Research Laboratory, Department of Pediatrics and Adolescent Medicine, Rigshospitalet University of Copenhagen  Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte Aalund","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology Lillebaelt University Hospital Vejle  Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna Skov","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology Lillebaelt University Hospital Vejle  Odense Denmark"},{"name":"Department of Regional Health Research University of Southern Denmark  Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Clinic of Pediatric Oncology and Hematology Rigshospitalet University of Copenhagen  Denmark"},{"name":"Pediatric Oncology Research Laboratory, Department of Pediatrics and Adolescent Medicine, Rigshospitalet University of Copenhagen  Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Mathiasen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Clinic of Pediatric Oncology and Hematology Rigshospitalet University of Copenhagen  Denmark"},{"name":"Pediatric Oncology Research Laboratory, Department of Pediatrics and Adolescent Medicine, Rigshospitalet University of Copenhagen  Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-4389","authenticated-orcid":false,"given":"Tore Bjerregaard","family":"Stage","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health University of Southern Denmark University of Southern Denmark  Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v26.5.642.642"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12114"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20104642(18)30236\u20100"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280\u2010019\u201003884\u20105"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.04.004"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.09.005"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2017.12.019"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010021\u201001484\u2010y"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529\u20108027.2009.00230.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26471"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010013\u20101981\u20106"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0b013e318299ad23"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1400972"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.104729"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018309"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24954"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582\u2010018\u20100058\u2010z"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp\u20102018\u2010320106"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002840"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154395"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.08.001"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163939"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01893697\u2010200927030\u201000002"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15537"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11121004"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2018.06.005"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0894"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2023.2251003"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70599","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70599","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:38:13Z","timestamp":1787819893000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/bcp.70599"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70599","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}